What happened
Jinxin Fertility launched a specialized AI agent for in vitro fertilization treatment in China. The system assists clinicians with data analysis and decision support during treatment. The tool directly targets medical staff rather than patients.
The context
Hospitals are moving from general chatbots to domain-specific clinical tools. Reproductive medicine relies on heavy patient tracking, making it a logical target for automated assistance.
Sources
- thebambooworks.com ↗ via Google News Reported